| HOME >> BIOLOGY >> TECHNOLOGY |
Partnership will develop proprietary medical food, functional food, and dietary supplement products with strong scientific roots and clinical support for burgeoning markets
North Brunswick, NJ and Blauvelt, NY (PRWEB) December 17, 2009 -- WellGen, Inc., a biotechnology company at the crossroads of foods and pharmaceuticals, and RFI Ingredients, a manufacturer of innovative natural ingredients, are pleased to announce the signing of a Memorandum of Understanding (MOU) covering a range of areas for cooperation. The new partnership is designed to enhance the business of both companies and bring exciting new natural products to the market. Products will have a strong base in science, solid clinical support, and affirmed GRAS (generally recognized as safe) status.
The MOU serves as a framework for collaboration on several high-growth opportunities: the creation of new medical foods for people with inflammation-related diseases for which there are major unmet needs; the creation of new dietary supplement and functional food products for consumer and health care professional markets; and the development and supply of natural ingredients with strong scientific and clinical support.
Commenting on the new relationship, Dr. Roddy Carter, president and chief executive officer of WellGen, states “the complementary skills of WellGen and RFI Ingredients will work synergistically to enhance the companies’ natural product offerings. Both companies have been acknowledged for their innovation and share a common interest in developing proprietary, high-quality products supported by strong clinical evidence. This collaboration will couple WellGen’s scientific and clinical know-how with RFI’s infrastructure and expertise in the natural products market. “
'/>"/>| Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved |